Document is current
Any future updates will be listed below
-
Authors
Ochando, Jordi https://orcid.org/0000-0001-7037-1681
Ortiz, Alberto https://orcid.org/0000-0002-9805-9523
- License Information
-
More Information
Article History
First Online: 6 January 2025
Competing interests
: J.O. is scientific founder of Trained Therapeutics Discovery. A.O. has received consultancy fees, speaker fees or travel support from Astellas, AstraZeneca, Bioporto, Boehringer Ingelheim, Fresenius Medical Care, GSK, Bayer, Sanofi-Genzyme, Sobi, Menarini, Lilly, Chiesi, Otsuka, Novo-Nordisk, Sysmex, Vifor Fresenius Medical Care Renal Pharma and Spafarma, is the Director of the Catedra UAM-AstraZeneca of chronic kidney disease and electrolytes, and has stock in Telara Farma.
